CASI - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CASI Pharmaceuticals

CASI Pharmaceuticals is implementing eco-friendly packaging standards and minimizing harmful emissions during drug synthesis. CASI Pharmaceuticals generates profit by adapting Western target molecules to PRC regulations, leveraging the low demand elasticity within onco-hematology. The EV/EBITDA market trend at 0.00 complements data on stable management, which effectively integrates the drug portfolio into state healthcare networks.

CASI CASI Pharmaceuticals Inc.: Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ing interval 23.11.2025 - 14.03.2026

casipharmaceuticals.com - rincian analitis lan metrik utama (CASI)

- rega saiki lan proyeksi nilai saham:

Rega saham CASI Pharmaceuticals, Inc.|CASI - Bagan rega target

- statistik kapitalisasi pasar:

Nilai pasar CASI Pharmaceuticals, Inc|CASI - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham CASI Pharmaceuticals|CASI - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku casipharmaceuticals.com|CASI - Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Total Utang marang Modal CASI Pharmaceuticals|CASI - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal CASI Pharmaceuticals, Inc.|CASI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku CASI Pharmaceuticals, Inc|CASI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CASI Pharmaceuticals|Rasio cepet casipharmaceuticals.com

- data bathi bisnis lan rasio investasi:

CASI - Asil keuangan resik|Bathi mangsa ngarep CASI Pharmaceuticals|CASI - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep CASI Pharmaceuticals, Inc.|CASI - Rasio kapitalisasi marang bathi lan wutah|Pangali EV/EBITDA CASI Pharmaceuticals, Inc|CASI - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) CASI Pharmaceuticals|CASI - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan casipharmaceuticals.com|CASI - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CASI Pharmaceuticals

Analisis kabeh metrik perusahaan:CASI Pharmaceuticals, Inc CASI

To assess an asset's operational resilience, an investor analyzes the ratio of enterprise value to earnings before interest, taxes, depreciation, and amortization, which allows the EV/EBITDA multiple chart to determine the degree of price overheating relative to actual cash flows. In the case of CASI Pharmaceuticals (CASI), this metric confirms the effectiveness of commercializing Wei-Wu He's Western innovations by linking market capitalization to the growth rates of the drug portfolio.

Pesaing CASI Pharmaceuticals